Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017 (2017), Article ID 4237973, 8 pages
https://doi.org/10.1155/2017/4237973
Research Article

Schisandrin B Prevents Hind Limb from Ischemia-Reperfusion-Induced Oxidative Stress and Inflammation via MAPK/NF-κB Pathways in Rats

1Department of Cardiology, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui Central Hospital, Zhejiang Province 323000, China
2Department of Cardiology, The Third Clinical College of Wenzhou Medical University, Wenzhou People’s Hospital, Wenzhou, Zhejiang Province 325000, China

Correspondence should be addressed to Chunlai Zeng; nc.moc.liamdem@ialnuhcgnez

Received 8 March 2017; Revised 7 May 2017; Accepted 21 May 2017; Published 19 June 2017

Academic Editor: Pankaj K. Bhavsar

Copyright © 2017 Ning Zhu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. J. Percival and T. E. Rasmussen, “Reperfusion strategies in the management of extremity vascular injury with ischaemia,” British Journal of Surgery, vol. 99, Supplement 1, pp. 66–74, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. W. R. Hiatt, E. J. Armstrong, C. J. Larson, and E. P. Brass, “Pathogenesis of the limb manifestations and exercise limitations in peripheral artery disease,” Circulation Research, vol. 116, no. 9, pp. 1527–1539, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. J.-P. Estebe, J. M. Davies, and P. Richebe, “The pneumatic tourniquet: Mechanical, ischaemia-reperfusion and systemic effects,” European Journal of Anaesthesiology, vol. 28, no. 6, pp. 404–411, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. M. D. Seekamp and P. A. Ward, “Ischemia-reperfusion injury,” Agents and Actions. Supplements, vol. 41, pp. 137–152, 1993. View at Google Scholar · View at Scopus
  5. M. J. Concannon, C. G. Kester, C. F. Welsh, and C. L. Puckett, “Patterns of free-radical production after tourniquet ischemia: implications for the hand surgeon,” Plastic and Reconstructive Surgery, vol. 89, no. 5, pp. 846–852, 1992. View at Publisher · View at Google Scholar · View at Scopus
  6. J. M. McCord, “The evolution of free radicals and oxidative stress,” The American Journal of Medicine, vol. 108, no. 8, pp. 652–659, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. G. B. Bulkley, “Free radicals and other reactive oxygen metabolites: clinical relevance and the therapeutic efficacy of antioxidant therapy,” Surgery, vol. 113, no. 5, pp. 479–483, 1993. View at Google Scholar · View at Scopus
  8. L. Guo, L. Wang, H. Li et al., “Down regulation of GALNT3 contributes to endothelial cell injury via activation of p38 MAPK signaling pathway,” Atherosclerosis, vol. 245, pp. 94–100, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Jacquet, E. Zarrinpashneh, A. Chavey et al., “The relationship between p38 mitogen-activated protein kinase and AMP-activated protein kinase during myocardial ischemia,” Cardiovascular Research, vol. 76, no. 3, pp. 465–472, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Zhang, J. Xia, Y. Zhang et al., “HMGB1-TLR4 signaling participates in renal ischemia reperfusion injury and could be attenuated by dexamethasone-mediated inhibition of the ERK/NF-κB pathway,” American Journal of Translational Research, vol. 8, no. 10, pp. 4054–4067, 2016. View at Google Scholar · View at Scopus
  11. D. Y. Zheng, M. Zhou, J. Jin et al., “Inhibition of P38 MAPK downregulates the expression of IL-1β to protect lung from acute injury in intestinal ischemia reperfusion rats,” Mediators of Inflammation, vol. 2016, Article ID 9348037, 8 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Li, B. Xu, M. Xu et al., “6-Gingerol protects intestinal barrier from ischemia/reperfusion-induced damage via inhibition of p38 MAPK to NF-κB signalling,” Pharmacological Research, vol. 119, pp. 137–148, 2017. View at Publisher · View at Google Scholar
  13. H. Yu, L. Shi, G. Qi, S. Zhao, Y. Gao, and Y. Li, “Gypenoside protects cardiomyocytes against ischemia-reperfusion injury via the inhibition of mitogen-activated protein kinase mediated nuclear factor kappa B pathway in vitro and in vivo,” Frontiers in Pharmacology, vol. 7, article 148, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Panossian and G. Wikman, “Pharmacology of Schisandra chinensis Bail.: an overview of Russian research and uses in medicine,” Journal of Ethnopharmacology, vol. 118, no. 2, pp. 183–212, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. G. t. Liu, “Pharmacological actions and clinical use of fructus schizandrae,” Chinese Medical Journal, vol. 102, no. 10, pp. 740–749, 1989. View at Google Scholar · View at Scopus
  16. R. A. Thandavarayan, V. V. Giridharan, S. Arumugam et al., “Schisandrin B prevents doxorubicin induced cardiac dysfunction by modulation of DNA damage, oxidative stress and inflammation through inhibition of mapk/p53 signaling,” PLoS One, vol. 10, no. 3, Article ID e0119214, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. P. K. Leong, P. Y. Chiu, N. Chen, H. Leung, and K. M. Ko, “Schisandrin B elicits a glutathione antioxidant response and protects against apoptosis via the redox-sensitive ERK/Nrf2 pathway in AML12 hepatocytes,” Free Radical Research, vol. 45, no. 4, pp. 483–495, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Y. Chiu, D. H. Mak, M. K. T. Poon, and K. M. Ko, “Role of cytochrome P-450 in schisandrin B-induced antioxidant and heat shock responses in mouse liver,” Life Sciences, vol. 77, no. 23, pp. 2887–2895, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. P. K. Leong and K. M. Ko, “Schisandrin B induces an Nrf2-mediated thioredoxin expression and suppresses the activation of inflammasome in vitro and in vivo,” BioFactors, vol. 41, no. 5, pp. 314–323, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Chen, S. Pang, N. Yang et al., “Beneficial effects of schisandrin B on the cardiac function in mice model of myocardial infarction,” PLoS One, vol. 8, no. 11, Article ID e79418, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. T. H. Lee, C. H. Jung, and D. H. Lee, “Neuroprotective effects of Schisandrin B against transient focal cerebral ischemia in Sprague-Dawley rats,” Food and Chemical Toxicology, vol. 50, no. 12, pp. 4239–4245, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Takhtfooladi, M. Takhtfooladi, F. Moayer, and S. Mobarakeh, “Melatonin attenuates lung injury in a hind limb ischemia-reperfusion rat model,” Revista Portuguesa de Pneumologia, vol. 21, no. 1, pp. 30–35, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Zhu, D. X. Wang, W. Zhang et al., “Andrographolide protects against LPS-Induced Acute Lung Injury by Inactivation of NF-κB,” PLoS One, vol. 8, no. 2, Article ID e56407, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Kirisci, G. L. Oktar, C. Ozogul et al., “Effects of adrenomedullin and vascular endothelial growth factor on ischemia/reperfusion injury in skeletal muscle in rats,” Journal of Surgical Research, vol. 185, no. 1, pp. 56–63, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Harris, P. M. Walker, D. A. Mickle et al., “Metabolic response of skeletal muscle to ischemia,” American Journal of Physiology, vol. 250, pp. H213–H220, 1986. View at Google Scholar
  26. T. J. Percival and T. E. Rasmussen, “Reperfusion strategies in the management of extremity vascular injury with ischaemia,” British Journal of Surgery, vol. 99, no. 1, pp. 66–74, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. X. T. Wang, Y. Tian, W. X. Xu et al., “Protective effects of modeled superoxide dismutase coordination compound (MSODa) against ischemia/reperfusion injury in rat skeletal muscle,” Cellular Physiology and Biochemistry, vol. 37, no. 2, pp. 465–476, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. M. A. Takhtfooladi, A. Asghari, H. A. Takhtfooladi, and S. Shabani, “The protective role of curcumin on testicular tissue after hindlimb ischemia reperfusion in rats,” International Urology and Nephrology, vol. 47, no. 10, pp. 1605–1610, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. M. A. Takhtfooladi, A. Jahanshahi, A. Sotoudeh, M. H. Daneshi, M. Khansari, and H. A. Takhtfooladi, “The antioxidant role of n-acetylcysteine in testicular remote injury after skeletal muscle ischemia and reperfusion in rats,” Polish Journal of Pathology, vol. 64, no. 3, pp. 204–209, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Zhao, Q. Feng, Z. Huang et al., “Simvastatin inhibits inflammation in ischemia-reperfusion injury,” Inflammation, vol. 37, no. 5, pp. 1865–1875, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Chu, W. He, Y. Kuang, K. Ren, and X. Gou, “Celastrol protects kidney against ischemia-reperfusion-induced injury in rats,” Journal of Surgical Research, vol. 186, no. 1, pp. 398–407, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Z. He, K. G. Zhou, R. Zhang, Y. K. Wang, and X. F. Chen, “Impact of intestinal ischemia/reperfusion and lymph drainage on distant organs in rats,” World Journal of Gastroenterology, vol. 18, no. 48, pp. 7271–7278, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. D. G. Souza, G. D. Cassali, S. Poole, and M. M. Teixeira, “Effects of inhibition of PDE4 and TNF-α on local and remote injuries following ischaemia and reperfusion injury,” British Journal of Pharmacology, vol. 134, no. 5, pp. 985–994, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Gupta and A. R. Nebreda, “Roles of p38α mitogen-activated protein kinase in mouse models of inflammatory diseases and cancer,” FEBS Journal, vol. 282, no. 10, pp. 1841–1857, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. W. He, F. Shi, Z. W. Zhou et al., “A bioinformatic and mechanistic study elicits the antifibrotic effect of ursolic acid through the attenuation of oxidative stress with the involvement of ERK, PI3K/Akt, and p38 MAPK signaling pathways in human hepatic stellate cells and rat liver,” Drug Design, Development and Therapy, vol. 9, pp. 3989–4104, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Zhou, D. Zhao, H. An, H. Zhang, C. Jiang, and B. Yang, “Melatonin prevents lung injury induced by hepatic ischemia-reperfusion through anti-inflammatory and anti-apoptosis effects,” International Immunopharmacology, vol. 29, no. 2, pp. S1567–S5769, 2015. View at Publisher · View at Google Scholar
  37. M. Qi, L. Zheng, Y. Qi et al., “Dioscin attenuates renal ischemia/reperfusion injury by inhibiting the TLR4/MyD88 signaling pathway via up-regulation of HSP70,” Pharmacological Research, vol. 100, pp. 341–352, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Zhang, Y. Qi, Y. Xu et al., “Protective effect of flavonoid-rich extract from Rosa laevigata Michx on cerebral ischemia-reperfusion injury through suppression of apoptosis and inflammation,” Neurochemistry International, vol. 63, no. 5, pp. 522–532, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. P. J. Barnes and M. Karin, “Nuclear factor-κB—a pivotal transcription factor in chronic inflammatory diseases,” The New England Journal of Medicine, vol. 336, no. 15, pp. 1066–1071, 1997. View at Publisher · View at Google Scholar · View at Scopus
  40. Z. Sun and R. Andersson, “NF-κB activation and inhibition: a review,” Shock, vol. 18, no. 2, pp. 99–106, 2002. View at Publisher · View at Google Scholar · View at Scopus